Despite its inhibitory effect on extravasation and tissue infiltration in myeloid sarcoma, loss of RKIP seems to be a marker for good prognosis in AML [54], contrary to solid tumors. The gene discussed is PEBP1; the disease is acute myeloid leukemia.